Neueste Beiträge

• Norwegian Start-up KinSea Announces First Closing of Seed Financing
• CasInvent Pharma Raises € 1.6 million in Pre-Series A Financing to Support the Development of CK1 Inhibitors for Treatment-Resistant Solid and Hematological Tumours
• Nodus Oncology raises £1.8m ($2.3m) to extend its seed funding
• Lead Discovery Center GmbH licenses next-generation anticancer drug candidate to HLB Life Science R&D
• Norwegian Start-up KinSea to Exploit the Potential of Marine Bioactives for the Treatment of Cancer and other Diseases